|
|
||||||||
1 Division of Cardiology, Department of Medicine, Johns Hopkins Medical Center, Baltimore, Maryland 21224; and 2 Department of Veterinary Biosciences, 3 Department of Food Science and Human Nutrition, and 4 Department of Animal Sciences, University of Illinois, Urbana-Champaign, Illinois 61802
| |
ABSTRACT |
|---|
|
|
|---|
We investigated the effects of phytoestrogen on global myocardial ischemia-reperfusion injury in five groups of female rats. A high-phytoestrogen group (HPE) was ovariectomized (Ovx) and fed a diet containing soybean protein and a high-isoflavone soy extract. Another Ovx group of rats was fed the same diet as the HPE group but treated with the estrogen receptor blocker ICI-182,780 (HPE + ICI). A third group of Ovx rats was fed a diet containing soybean protein alone (low-phytoestrogen content; LPE). A fourth Ovx group was fed a diet free of phytoestrogen (Ovx). The fifth group of rats was sham ovariectomized (sham). Hearts from all rats were subjected to 30 min of global, hypothermic (4°C), cardioplegic ischemia and 120 min of normothermic (37°C) reperfusion with oxygenated Krebs-Henseleit buffer. Compared with either the sham or the HPE group, the Ovx and HPE + ICI groups had significantly decreased first derivative of left ventricular pressure (dP/dt), coronary flow rate (CFR), nitrite production and mitochondrial respiratory function and significantly increased Ca2+ accumulation and myocardial histological and ultrastructural injury. The CFR of the LPE group was significantly different from that of either Ovx or HPE + ICI group but the dP/dt, nitrite production, Ca2+ accumulation, and mitochondrial function were not. Our results indicate that diets containing phytoestrogen extract play a cardioprotective role in global myocardial ischemia-reperfusion in female rats.
calcium; nitric oxide; cardioplegia; mitochondrial function; myocardial ultrastructure
| |
INTRODUCTION |
|---|
|
|
|---|
WE HAVE PREVIOUSLY REPORTED that estrogen has protective effects against myocardial injury caused by global, hypothermic, cardioplegia-induced myocardial ischemia, followed by crystalloid reperfusion in both male mice (37) and female rats (38). Estrogen has also been reported to inhibit high-potassium cardioplegia-induced Ca2+ overload in cultured cardiac myocytes (17).
Phytoestrogens are natural nonsteroidal plant-derived compounds. The major classes of phytoestrogens of current interest are isoflavones. Soy products are rich sources for isoflavones. The primary soy-derived isoflavones are genistein, daidzein, and glycitein. Their structures are similar to the structure of estrogen, and they bind to estrogen receptors (20).
A diet containing soy proteins was found to lower plasma concentration of total cholesterol, low-density lipoprotein cholesterol, and very-low-density cholesterol and increase plasma concentrations of high-density lipoprotein cholesterol in young women (36). Female macaques fed a soy protein diet for 6 mo demonstrated enhanced coronary dilatation in response to acetylcholine. Those fed a similar soy protein diet, but with isoflavones removed by ethanol extraction, demonstrated constriction in response to acetylcholine (14). Genistein and daidzein inhibited mitogen-induced proliferation, migration, and extracellular matrix synthesis in cultured human aortic smooth muscle cells (7). Genistein was shown to inhibit intimal thickening and replication in carotid arteries after denudation injury in rats in vivo and to inhibit smooth muscle cell proliferation and migration in vitro (24). Intravenous administration of 1 mg/kg genistein to rats 5 min after the occlusion of the left main coronary artery lowered myocardial necrosis, decreased serum creatine kinase activity, increased myocardial contractility, and decreased the occurrence of ventricular arrhythmias (6). It is unknown whether dietary phytoestrogen has any effect on myocardial ischemia-reperfusion injury.
The experiments reported here were designed to 1) demonstrate if dietary phytoestrogen has any protective activity in global, cardioplegia-protected ischemia, followed by reperfusion, and, if so, 2) to gain information about the potential mechanisms for the cardioprotective effects.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Experimental animals.
All experiments involving animals were approved by the
Institutional Animal Care and Use Committee of the University of
Illinois at Urbana-Champaign and were conducted in strict accordance
with the NIH Guide for the Care and Use of Laboratory
Animals (National Research Council, 1996). Fifty female
Sprague-Dawley rats (3 mo old) were purchased from Harlan Sprague
Dawley (Indianapolis, IN) and fed standard rat chow for 3 mo. At an age
of 6 mo, 10 rats were prepared as sham-operated controls (sham). All
other rats (n = 40) were ovariectomized (Ovx) and
divided into four groups. The anesthesia, Ovx, and sham surgery
procedures have been previously described (38). Briefly,
the rats were anesthetized with ketamine (20 µg/g ip) and xylazine
(0.5 µg/g ip). On each side, the skin was prepared for aseptic
surgery and a lateral paralumbar incision was made. The ovary on that
side was isolated and removed with the oviduct. Sham animals had the
ovaries isolated but left intact. The incisions were closed with
stainless steel wound clips that were removed in 7-10 days. Each
group was fed one of the diets described in Table
1. The phytoestrogen isoflavone content
in the diet containing soybean protein and soybean protein plus soy
extract is summarized in Table 2. The Ovx
control rats (n = 10) and sham rats were fed a diet
supplemented with 200 g/kg of casein, i.e., no dietary phytoestrogen.
The low-phytoestrogen (LPE) diet group (n = 10)
received 200 g/kg soybean proteins instead of the casein, and the
high-phytoestrogen diet groups [HPE, n = 10, and
HPE + ICI-187,780 (ICI), n = 10] were both fed
200 g/kg soy protein diets plus 34.4 g/kg high-isoflavone soy protein
extract. The HPE + ICI group was additionally treated with a
weekly subcutaneous injection of ICI in castor oil vehicle at a dose of
10 mg/kg. The dose of ICI was selected based on results of a study by
other faculty in the same department. This study (26)
showed maximum testicular effects in rats from the same dose. Rats were
fed the special diets for 3 mo and used in the described experimental protocol when they were approaching reproductive senescence, i.e., >9
mo old (1).
|
|
Experimental protocol.
Rats were anesthetized as previously described and treated with
heparin (1,000 IU ip). The heart was quickly removed, weighed, and
immersed in cardioplegic solution [Plegisol (Abbott Labs) plus 25 mmol/l NaHCO3 and 2 U/ml heparin]; pH 7.4 at 4°C. The same cardioplegic solution was infused retrograde into the coronary arteries through an aortic catheter with the use of a speed-controlled roller pump at an infusion rate of 0.3 ml/min for 5 min. A
balloon-tipped catheter was inserted into the left ventricle (LV) via
the left atrium and secured. Infusion of the cardioplegic solution was then stopped, and the heart was immersed in the same cold cardioplegic solution for a total ischemia time of 30 min. The heart was
mounted in a Langendorff-type isolated heart perfusion system with a
water jacket-warmed organ chamber, oxygenator, and reservoir. The
hearts were subjected to 2 h of retrograde coronary artery
reperfusion with Krebs-Henseleit bicarbonate buffer (Sigma) oxygenated
with 95% O2-5% CO2, pH 7.4 and 37°C, at a
constant pressure of 120 cmH2O. All hearts were converted
to sinus rhythm spontaneously and were allowed to beat at their own
rhythm, i.e., not paced. LV pressure (LVP) was continuously measured
for the duration of reperfusion using a Digi-MED Heart Performance
Analyzer-
(Micro-Med). Heart rate, maximum LVP, end-diastolic LVP,
and the first derivative of LVP (dP/dt) were continuously
recorded using a computer installed with Digi-MED System software
(MicroMed). The end-diastolic LVP was set so as not to exceed 10 mmHg
by adjusting the volume in the balloon at the beginning of the
perfusion period. The balloon volume was then kept constant throughout
the 120-min reperfusion time. Coronary flow rate (CFR), coronary
nitrite concentration, and Ca2+ concentrations in both
coronary inflow and effluent were measured during the 120 min of
reperfusion as previously described (36). Briefly,
coronary flow rate (in ml · min
1 · 100 g
1) was measured by collecting the coronary effluent
volume for a total of 120 min. This volume was divided by the time and
normalized by the wet weight of the heart (g), measured at the
beginning of the experiment. Nitrite production (nmol/g) was estimated
as the product of coronary nitrite concentration, which was measured using the Griess reaction (12), and coronary effluent
volume normalized by heart wet weight (g), which was not significantly different among the experimental groups. Myocardial Ca2+
accumulation (µmol/g) was estimated from the difference in
Ca2+ concentration (µmol/ml) and was measured using
inductively coupled plasma atomic emission spectrometry between
perfusate and effluent. This was normalized by coronary effluent volume
(ml) and the heart wet weight (g).
Measurement of plasma isoflavones.
At the time the heart was isolated, blood plasma was collected and
stored at
20°C until used for measuring isoflavones. The concentration of genistein and daidzein in plasma were measured using a
high-performance liquid chromatograph and mass spectrometry (HPLC-MS)
method (4). The isoflavone conjugates in plasma were hydrolyzed by using
-glucuronidase-sulfatase (Helix pomatia type H-2, Sigma). A 0.5-ml sample of plasma was incubated with 609.5 units
of
-glucuronidase and 25 units of sulfatase and 200 µl of 10 nM
ammonium acetate buffer at 37°C for 16 h. The isoflavone extracts were then extracted according to the method reported by Lundh
et al. (22). The overall recovery efficiency was >80% for both genistein and daidzein (92% for enzyme digestion and 90% for
extraction). Biochanin A was used as the internal standard in this
assay procedure. The isoflavone extracts were redissolved in 30%
acetonitrile in 10 mM ammonium acetate buffer and measured using a
Waters 2690 HPLC-MS. HPLC separation was performed on a Waters Xterra
MS C18 reverse-phase HPLC column with 3.5-µm particle size and 125-Å
pore size under isocratic conditions (40% acetonitrile in 10 mM
ammonium acetate) at a flow rate of 0.3 ml/min. The single-ion resolution scan function was used for MS analysis after
electrospray-negative ionization. The measuring mass charge ratio was
set at 269.2 (genistein) and 253.2 (daidzein), respectively. The peak
of interest on the chromatogram was identified according to the
chromatogram of genistein and daidzein standards, respectively. The
integration of peak areas was carried out using the MassLynx software,
provided by the mass spectrometer manufacturer. The peak areas were
compared with a series of known concentrations of genistein and
daidzein standards to estimate the plasma genistein and daidzein concentrations.
Measurement of plasma estradiol concentration.
Plasma (1 ml) was used for measuring 17
-estradiol concentration
using a radioimmunoassay kit, as previously described
(38).
Statistical analysis.
All data are presented as means ± SE and were first analyzed
using a two-way analysis of variance (ANOVA) for repeated measures or a
single-factor ANOVA as appropriate. If significant differences were
observed, a Bonferroni t-test was applied to compare
differences between groups. Statistical analyses were done by running
appropriate SAS procedures (SAS Institute; Cary, NC). All proportions
were compared using a
2 test. The
-level was set at
0.05 and adjustment was made to control experiment type I error where appropriate.
| |
RESULTS |
|---|
|
|
|---|
The body weights of the animals were (in g) sham, 322.5 ± 37.2; Ovx, 378.4 ± 25.8; LPE, 334.3 ± 30.7; HPE, 361.8 ± 24.3; and HPE + ICI, 367.0 ± 21.6. The wet heart weights before reperfusion were (in g) sham, 1.63 ± 0.15; Ovx, 1.58 ± 0.15; LPE, 1.31 ± 0.9; HPE, 1.49 ± 0.13; and HPE + ICI, 1.52 ± 0.16. The heart weight-to-body weight ratios were (in %) sham, 0.51 ± 0.07; Ovx, 0.42 ± 0.05; LPE, 0.39 ± 0.03; HPE, 0.41 ± 0.13; and HPE + ICI, 0.415 ± 0.05. A representative number of hearts from each group were also weighed after reperfusion but in no instance was the weight after reperfusion >0.1-0.02 g than the prereperfusion weight.
Plasma genistein and daidzein concentration. Plasma genistein concentration was 226.02 ± 79.67 ng/ml in those rats fed the HPE diet (HPE and HPE + ICI groups). The average plasma genistein concentration was 20.71 ± 2.33 ng/ml in the LPE group, which was significantly lower than that of the HPE and the HPE + ICI groups (P < 0.01). The concentration of plasma genistein averaged 5.17 ± 0.51 ng/ml in the phytoestrogen-free diet rats (sham and Ovx groups), which was significantly lower than that in the HPE and the HPE + ICI groups (P < 0.0001) and that of the LPE group (P < 0.01). The plasma daidzein concentration was 147.85 ± 50.8 ng/ml in the HPE and the HPE + ICI groups, which was significantly higher than that of the LPE group (18.98 ± 1.9 ng/ml, P < 0.001) and than that of the sham and the Ovx groups (8.1 ± 0.98 ng/ml, P < 0.01).
Plasma 17
-estradiol concentration.
Plasma 17
-estradiol concentration averaged 60 ± 6 pg/ml in the
sham group. The average plasma estradiol concentration of Ovx, HPE,
LPE, and HPE + ICI groups was 27 ± 1 pg/ml, which was significantly lower than that of the sham group (P < 0.0001).
LV dP/dt.
The average LV dP/dt of the sham group during the 120 min of
recording was 2,658.9 ± 92.6 mmHg/s, which was significantly higher than that of the Ovx group (1,756.3 ± 129.2 mmHg/s). HPE significantly improved LV function with an average LV dP/dt
of 2,724.6 ± 118.2 mmHg/s, which was significantly higher than
that of the Ovx group but not significantly different than that of the
sham group (Fig. 1). The estrogen
receptor blocker ICI abolished the effect of HPE on LV dP/dt
(1,873.4 ± 148.9), significantly lower than that of the
HPE group and the sham group but not significantly different from that
of the Ovx group (Fig. 1). The LPE group LV dP/dt was not
significantly different than that of either the Ovx group or the
HPE + ICI group (Fig. 1).
|
Coronary flow rate.
The CFR in the sham group averaged 9.07 ± 0.85 ml · min
1 · 100 g
1. The HPE
group had a CFR of 10.85 ± 0.48 ml · min
1 · 100 g
1 and the
LPE group averaged slightly less. There were no statistically significant differences between the sham, HPE, and LPE groups, but all
three had significantly higher flows than the HPE + ICI group
(8.12 ± 0.69 ml · min
1 · 100 g
1) and the Ovx group (6.98 ± 0.70 ml · min
1 · 100 g
1) (Fig.
2).
|
Nitrite production.
The sham group averaged 2.77 ± 0.44 nmol · min
1 · g
1 nitrite
during reperfusion and the HPE group averaged 2.21 ± 0.16 nmol · min
1 · g
1 (Fig.
3). The nitrite production of the Ovx
group was 1.05 ± 0.11 nmol · min
1 · g
1, which was
significantly less than that of the sham and HPE groups. The HPE + ICI group only produced an average 0.84 ± 0.04 nmol · min
1 · g
1, which was
significantly less than that of either the sham group or the HPE group
but not the Ovx group. The LPE group was not different than either the
Ovx or the HPE + ICI group.
|
Myocardial Ca2+ accumulation.
Over the 120 min of reperfusion, there were no significant differences
in the amount of Ca2+ between the perfusate and the
effluent in the sham and HPE + ICI groups. The HPE group
demonstrated an apparent Ca2+ export, i.e., negative
accumulation. There was a significant accumulation of Ca2+
in the hearts of the Ovx and LPE groups compared with the other three
groups (Fig. 4).
|
Myocardial MTT extraction.
After ischemia-reperfusion, myocardial MTT reduction in the Ovx,
HPE + ICI, and LPE groups was significantly lower than that in the
sham and HPE groups. The latter were not significantly different from each other (Fig. 5). The
HPE + ICI group had the lowest myocardial MTT reduction but was
not significantly lower than that in the Ovx and LPE groups.
|
Myocardial histology.
Representative slides from animals from each group are shown in Figs. 6
and 7. After ischemia-reperfusion, prominent interstitial edema
was present on H-E-stained tissue sections from the Ovx (Fig.
6B), the HPE + ICI (Fig.
6D), and the LPE (Fig. 6E) samples, whereas only
slight edema was demonstrated in the sham (Fig. 6A) and the
HPE samples (Fig. 6C). The amount of edema in the HPE + ICI samples was not different from that of the Ovx samples, and the HPE
group was not different from the sham group. These results were
obtained from samples from all animals using NIH Image software (Fig.
6F). In the Ovx, the HPE + ICI, and the LPE samples
nonuniformly stained myofibrils are visible. This may be the result of
loss of contractile materials.
|
|
Myocardial ultrastructure.
Representative transmission electron microscopic results from each
group of rats are shown in Fig. 8. The
myofibrils were intact in the sham samples (Fig. 8A). The
mitochondria were abnormal in appearance, but most of them contained
well-defined cristae. No significant intracellular edema was seen. In
the Ovx group (Fig. 8B), the clear sarcoplasmic spaces
probably indicate intracellular edema and/or loss of normal structures.
The mitochondria are obviously abnormal, swollen, and abnormal in
shape, and none contain clearly defined cristae. Most demonstrate
amorphous matrix densities or granular densities, which may represent
aggregation of proteins (such as denature enzymes) and/or deposition of
Ca2+ and phosphate (15, 19, 33). Some
mitochondria are fragmented and others have their matrix cleared out,
resulting in what appears to be vacuoles. The HPE samples (Fig.
8C) are not obviously different from the sham samples, i.e.,
they show mildly abnormal mitochondria and intact myofibrils. The
HPE + ICI samples (Fig. 8D) demonstrate intracellular
edema, swollen, fragmented, and vacuolated mitochondria, and
mitochondria with amorphous matrix inclusions and/or granular inclusions. Some mitochondria are without clearly defined cristae. These changes are very similar to those seen in the Ovx samples. The
LPE samples (Fig. 8E) also showed discontinuation of
myofibrils, mild intracellular edema, vacuolated mitochondria, and
swollen mitochondria with amorphous matrix inclusions and/or granular inclusions. Most of the mitochondria in these samples did not contain
sharply defined cristae. The observed changes in the mitochondria were
quantitatively indicated by the results of image analysis conducted on
samples from all animals (Fig. 9). The
cross-sectional areas of the mitochondria of the sham and HPE groups
were the same, but both were significantly smaller than those of the
Ovx and HPE + ICI groups (Fig. 9A). There was no
significant difference in cross-sectional area between the LPE group
and any of the other four. The percentage of mitochondria with granules
in the sham and HPE groups was significantly lower than that of the
Ovx, HPE + ICI, and LPE groups (Fig. 9B). The
percentage of fragmented mitochondria in the sham, HPE and LPE groups
was significantly lower than that of the Ovx and the HPE + ICI
groups.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
This study shows that dietary phytoestrogen increases circulating genistein and daidzein. Increased circulating genistein and daidzein apparently preserve myocardial structure and improve myocardial function after 30 min of global, hypothermic ischemia, followed by 120 min of normothermic crystalloid reperfusion in mature female rats. Our results also indicate that the protective effects of phytoestrogen in the HPE group are not significantly different from those of endogenous estrogen in the sham-operated group. These results point to a cardioprotective effect of the phytoestrogens genistein and daidzein. The experimental findings in this study do not completely rule out the potential beneficial systemic effects (i.e., on plasma lipids) of dietary phytoestrogens. However, the rat is a poor model of diet-induced cardiovascular disease, so it is difficult to comment on these issues.
Body weights, heart wet weights before reperfusion, and heart weight-to-body weight ratios tended to be less in the LPE group but were not statistically different between the five groups. This result was expected because all groups of rats were fed diets with balanced total caloric intake in controlled amounts.
Only some of the protective effects of phytoestrogens were blocked by
treatment with ICI, an anti-estrogen that is reported to block both the
- and
-estrogen receptors. Our results indicated that the
protective effects of phytoestrogen were mediated, in part, by
interacting with estrogen receptors. Soybean isoflavones are reported
to have weak estrogenic activity (5). They bind to both
estrogen receptor-
and estrogen receptor-
(20). They reportedly stimulated the transcriptional activity of estrogen receptor
that was inhibited by ICI in cell culture experiments (25). After oral intake, genistein labeled with
14C or its metabolites, was shown to accumulate in both
reproductive and peripheral tissues where estrogen receptors were
present (3). Both estrogen receptors have been
demonstrated in the coronary vasculature (30) and the
myocardium (12). We (37) previously reported
that male estrogen receptor-
knockout mice developed ventricular
arrhythmias and demonstrated marked myocardial damage following global
ischemia-reperfusion, suggesting an important role for estrogen
receptor-
during ischemia-reperfusion.
One potential mechanism of the cardioprotective effects of phytoestrogens is to maintain nitric oxide (NO) production during ischemia-reperfusion. The basal release of NO from isolated working rat hearts was reduced by ischemia-reperfusion (8). Endothelial NO synthase activity was decreased during ischemia and only partially restored during reperfusion (10). Inhibition of NO synthesis resulted in impaired postischemic recovery of function in isolated hearts (27). NO probably protects the myocardium by improving coronary flow (27) and decreasing the area of no reflow (29) under these experimental conditions. This study indicates that hearts from Ovx rats that had been supplemented with phytoestrogen produced significantly more nitrite than hearts from Ovx rats. This suggests that phytoestrogens maintained NO release. In this study, the effect of phytoestrogen on preserving myocardial systolic function, represented by increased dP/dtmax, did not totally depend on the effect of phytoestrogen on improving coronary flow, i.e., myocardial perfusion, suggesting that flow-mediated mechanisms alone are not sufficient to provide the protection observed. The differences in nitrite production between the LPE group and the Ovx group were not paralleled by those of coronary flow rate in this study, further suggesting that NO may exert protective effects through mechanisms beyond improving coronary flow.
Treatment with ICI in these studies blocked the effect of the
phytoestrogen extract on NO release. This suggests phytoestrogens act
by interacting with estrogen receptors in maintaining normal NO levels.
This may be important because an estrogen response element and
activator protein 1, both estrogen receptor-binding motifs, are present
in the NO synthase gene (28). In a previous study,
subcutaneous administration of genistein at a daily dose of 0.2 mg/kg
to Ovx rats for 4 wk increased the activity of
Ca2+-dependent NO synthase to the same extent as
17
-estradiol (34). Both endothelial NO synthase and
inducible NO synthase were expressed in endothelial cells, vascular
smooth muscle cells, and cardiac myocytes (28).
Phytoestrogens may maintain NO production by enhancing the activity and
the expression of NO synthase by interacting with estrogen receptors.
This, however, does not rule out other possible mechanisms through
which phytoestrogens may also regulate NO production.
Preserving mitochondrial structure and function may be another
mechanism of cardioprotection by phytoestrogens. It was reported (16) that mitochondria isolated from dog myocardium after
60 min of ischemia had only 3-4% of the capacity to
completely oxidize pyruvate to carbon dioxide and water. The activity
of electron transfer complex I (NADH-Q reductase) was decreased in
ischemic cardiac muscle (32). Structural changes
observed in dysfunctional mitochondria from the Jennings et al.
(16) study included relatively clear matrices, rare and
loosely packed cristae, and dense mitochondrial granules. A reduction
in energy production by mitochondria was shown to result in decreased
recovery of cardiac function after reperfusion (31).
17
-Estradiol reportedly stabilized mitochondrial function, i.e.,
prevented decreases in transmembrane potential and energy charge-redox
state, in neurons exposed to apoptotic agents (24).
Zheng and Ramirez (39) have demonstrated that the
oligomycin-sensitive-conferring protein, a subunit of the F0F1 mitochondrial ATP synthase-ATPase, is
required for coupling of a proton gradient across the F0
sector of the enzyme in the mitochondrial membrane. The protein plays a
role in ATP synthesis in the F1 sector of the enzyme and
binds to 17
-estradiol. The F0F1
mitochondrial ATP synthase-ATPase system is apparently responsible for
maintaining Ca2+ homeostasis in the mitochondria. Loss of
estrogen may block this function and result in Ca2+
accumulation within the mitochondria. In our previous study
(38), estrogen was shown to improve myocardial function by
preserving mitochondrial structure and mitochondrial function in female
rat hearts. In the present study, dietary phytoestrogen significantly inhibited mitochondrial swelling, reduced the number of mitochondria that were either fragmented, fragmented with granules, or unfragmented with granules, and improved myocardial MTT reduction. Treatment with
ICI significantly attenuated the effect of phytoestrogens on
mitochondrial function. This suggests that estrogen receptors are involved.
Phytoestrogens may also protect the myocardium against ischemia-reperfusion injury by inhibiting Ca2+ overload during ischemia-reperfusion. The occurrence of Ca2+ overload has been observed in isolated globally ischemic-reperfused rat hearts (35). A large increase in Ca2+ content occurred in severely damaged myocardium during reperfusion after prolonged ischemia (11). Ca2+ overload was reported (2) to depress the recovery of mechanical function of the myocardium. Dietary soy protein extract significantly inhibited Ca2+ accumulation during ischemia-reperfusion in these studies, whereas treatment with ICI did not block this effect. This suggests that phytoestrogens may inhibit Ca2+ entry through mechanisms independent of classical estrogen receptors, possibly related to the oligomycin-sensitive-conferring protein mechanism. Other studies have suggested an action of genistein, independent of estrogen receptor, in inhibiting Ca2+ entry. Genistein reportedly (9) antagonized Ca2+ entry in isolated rabbit coronary artery rings and inhibited L-type Ca2+ currents in guinea pig ventricular myocytes through an action not affected by ICI. Genistein was reported to inhibit L-type Ca2+ channel currents in rat ventricular myocytes by acting as a tyrosine kinase inhibitor. The possible mechanism was reported (18) to be influencing the phosphorylation level and thus decreasing the open probability of the channel.
To our knowledge, this study is the first indication that dietary phytoestrogens have a protective role during global, hypothermic, cardioplegia-protected ischemia, followed by normothermic reperfusion in rats. Our experimental results suggest that the protective effects of dietary phytoestrogens are the following: 1) maintaining NO release through classical estrogen receptor-mediated mechanisms, 2) preserving mitochondrial structure and function through the function of classical estrogen receptor, and 3) attenuating myocardial Ca2+ accumulation through mechanisms independent of classical estrogen receptor.
| |
ACKNOWLEDGEMENTS |
|---|
We greatly appreciate the assistance of Betty Ujhelyi, Joan Thompson, Sharon Meachum, Sherrie Lanzo, Alexander Reviera, and Dr. Victor Krylov. ICI-182,780 was a gift from Cancer and Infectious Research, Zeneca (Cheshire, United Kingdom). The soy protein and soy protein extract were gifts from Protein Technologies International (St. Louis, MO).
| |
FOOTNOTES |
|---|
This work was supported by Illinois Council for Food and Agricultural Research Grant 99I-066-4.
Address for reprint requests and other correspondence: D. R. Gross, Dept. of Veterinary Biosciences, 3516 VMBS Bldg., 2001 S. Lincoln Ave., Urbana, IL 61802 (E-mail: dgross{at}cvm.uiuc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 16 May 2001; accepted in final form 21 May 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Alkayed, NJ,
Murphy SJ,
Traystman RJ,
and
Hurn PD.
Neuroprotective effects of female gonadal steroids in reproductively senescent female rats.
Stroke
31:
161-168,
2000
2.
Bourdillon, PD,
and
Poole-Wilson PA.
The effects of verapamil, quiescence, and cardioplegia on calcium exchange and mechanical function in ischemic rabbit myocardium.
Circ Res
50:
360-368,
1982
3.
Coldham, NG,
and
Sauer MJ.
Pharmacokinetics of [(14)C] genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health.
Toxicol Appl Pharmacol
164:
206-215,
2000[ISI][Medline].
4.
Coward, L,
Kirk M,
Albin N,
and
Barnes S.
Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry.
Clin Chim Acta
247:
121-142,
1996[ISI][Medline].
5.
Davis, SR,
Murkies AL,
and
Wilcox G.
Phytoestrogens in clinical practice.
Integr Med
1:
27-34,
1998.
6.
Deodato, B,
Altavilla D,
Squadrito G,
Campo GM,
Arlotta M,
Minutoli L,
Saitta A,
Cucinotta D,
Calapai G,
Caputi AP,
Miano M,
and
Squadrito F.
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury.
Br J Pharmacol
128:
1683-1690,
1999[ISI][Medline].
7.
Dubey, RK,
Gillespie DG,
Imthurn B,
Rosselli M,
Jackson EK,
and
Keller PJ.
Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells.
Hypertension
33:
177-182,
1999
8.
Engelman, DT,
Watanabe M,
Engelman RM,
Rousou JA,
Flack JE, III,
Deaton DN,
and
Das DK.
Constitutive nitric oxide release is impaired after ischemia and reperfusion.
J Thorac Cardiovasc Surg
110:
1047-1053,
1995
9.
Figtree, GA,
Griffiths H,
Lu YQ,
Webb CM,
MacLeod K,
and
Collins P.
Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism.
J Am Coll Cardiol
35:
1977-1985,
2000
10.
Giraldez, RR,
Panda A,
Xia Y,
Sanders SP,
and
Zweier JL.
Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart.
J Biol Chem
272:
21420-21426,
1997
11.
Grinwald, PM.
Calcium uptake during post-ischemic reperfusion in the isolated rat heart: Influence of extracellular sodium.
J Mol Cell Cardiol
14:
359-365,
1982[ISI][Medline].
12.
Grohe, C,
Kahlert S,
Lobbert K,
and
Vetter H.
Expression of oestrogen receptor
and
in rat heart: role of local oestrogen synthesis.
J Endocrinol
156:
R1-R7,
1997.
13.
Guevara, I,
Iwanejko J,
Dembinxka-Kiee A,
Bartus S,
Malczewska-Malee M,
and
Szezudlik A.
Determination of nitrite/nitrate in human biological material by the simple Griess reaction.
Clin Chim Acta
274:
177-188,
1998[ISI][Medline].
14.
Honore, EK,
Williams JK,
Anthony MS,
and
Clarkson TB.
Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques.
Fertil Steril
67:
148-154,
1997[ISI][Medline].
15.
Itkonen, P,
and
Collan Y.
Mitochondrial flocculent densities in ischemia, digestion experiments.
Acta Pathol Microbiol Immunol Scand
91:
463-468,
1983.
16.
Jennings, RB,
Herdson PB,
and
Sommers HM.
Structural and functional abnormalities in mitochondria isolated from ischemic dog myocardium.
Lab Invest
20:
548-557,
1969[ISI][Medline].
17.
Jovanovic, S,
Jovanovic A,
Shen WK,
and
Terzic A.
Protective effects of 17 beta-estradiol in cardiac cells: implications for hyperkalemic cardioplegia.
Ann Thorac Surg
66:
1658-1661,
1998
18.
Katsube, Y,
Yokoshiki H,
Nguyen L,
Yamamoto M,
and
Sperelakis N.
Inhibition of Ca2+ current in neonatal and adult rat ventricular myocytes by the tyrosine kinase inhibitor, genistein.
Eur J Pharmacol
345:
309-314,
1998[ISI][Medline].
19.
Kloner, RA,
Ganote CE,
Whaler D,
and
Jennings RB.
Effect of a transient period of ischemia on myocardiac cells: II. Fine structure during the first few minutes of reflow.
Am J Pathol
74:
399-442,
1974[ISI][Medline].
20.
Kuipper, G,
Lemmen JG,
Carlson B,
Corton JC,
Safe SH,
van der Saag PT,
van der Burg B,
and
Gustafsson JA.
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
Endocrinology
139:
4252-4263,
1998
21.
Liu, Y,
Peterson DA,
Kimura H,
and
Schubert D.
Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.
J Neurochem
69:
581-593,
1997[ISI][Medline].
22.
Lundh, TJO,
Petersson H,
and
Kiesslilng KH.
Liquid chromatographic determination of the estrogens daidzein, formononetic, coumestrol, and equol in bovine blood plasma and urine.
J Assoc Anal Chem
71:
938-941,
1988.
23.
Makela, S,
Savolainen H,
Aavik E,
Myllarniemi M,
Strauss L,
Taskinen E,
Gustafsson JA,
and
Hayry P.
Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta.
Proc Natl Acad Sci USA
96:
7077-7082,
1999
24.
Mattson, MP,
Robinson N,
and
Guo Q.
Estrogens stabilize mitochondrial function and protect against the pro-apoptotic action of mutant presenilin-1.
Neuroreport
8:
3817-3821,
1997[ISI][Medline].
25.
Miksicek, RJ.
Commonly occurring plant flavonoids have estrogen activity.
Mol Pharmacol
44:
37-43,
1993[Abstract].
26.
Oliveira CA, Carnes K, Franca LR, and Hess RA. Infertility and
testicular atrophy in the antiestrogen-treated adult male rat.
Biol Repro. In press.
27.
Pabla, R,
and
Curtis MJ.
Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart.
J Mol Cell Cardiol
28:
2111-2121,
1996[ISI][Medline].
28.
Pappetropoulos, A,
Rudic RD,
and
Sessa WC.
Molecular control of nitric oxide synthases in the cardiovascular system.
Cardiovasc Res
43:
509-520,
1999
29.
Pernow, J,
and
Wang QD.
The role of L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury.
Acta Physiol Scand
167:
151-159,
1999[ISI][Medline].
30.
Register, TC,
and
Adams AR.
Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta.
J Steroid Biochem Mol Biol
64:
187-191,
1998[ISI][Medline].
31.
Reibel, DK,
and
Rovetto MJ.
Myocardial adenosine salvage rates and restoration of ATP content following ischemia.
Am J Physiol Heart Circ Physiol
237:
H247-H252,
1979.
32.
Rouslin, W.
Identification of mitochondrial dysfunction at coupling site I: loss of activity of NADH-ubiquinone oxidoreductase during myocardial ischemia.
In: Methods in Toxicology, Volume 2: Mitochondrial Dysfunction, edited by Lash LH,
and Jones DP.. San Diego, CA: Academic, 1993, p. 311-323.
33.
Schaper, J,
Heherlein F,
Schlepper M,
and
Thiedemann KU.
Ultrastructural alterations during ischemia and reperfusion in human hearts during cardiac surgery.
J Mol Cell Cardiol
9:
175-189,
1977[ISI][Medline].
34.
Squadrito, F,
Altavilla D,
Squadrito G,
Saitta A,
Cucinotta D,
Minutoli L,
Deodato B,
Ferlito M,
Campo GM,
Bova A,
and
Caputi AP.
Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats.
Cardiovasc Res
45:
454-462,
2000
35.
Steenbergen, C,
Murphy E,
Levy L,
and
London RE.
Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart.
Circ Res
60:
700-707,
1987
36.
Wang, M,
Yamamoto S,
Chung HM,
Chung SY,
Miyatani S,
Mori M,
Okita T,
and
Sugano M.
Antihypercholesterolemic effect of undigested fraction of soybean protein in young female volunteers.
J Nutr Sci Vitaminol (Tokyo)
41:
187-195,
1995[Medline].
37.
Zhai, P,
Eurell TE,
Cooke PS,
Lubahn DB,
and
Gross DR.
Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice.
Am J Physiol Heart Circ Physiol
278:
H1640-H1647,
2000
38.
Zhai, P,
Eurell TE,
Cotthaus R,
Jeffery EH,
Bahr JM,
and
Gross DR.
Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats.
Am J Physiol Heart Circ Physiol
279:
H2766-H2775,
2000
39.
Zheng, J,
and
Ramirez VD.
Purification and identification of an estrogen binding protein from rat brain: oligomycin sensitive-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase.
J Steroid Biochem Mol Biol
68:
65-75,
1999[ISI][Medline].
This article has been cited by other articles:
![]() |
M. J. Merkel, L. Liu, Z. Cao, W. Packwood, P. D. Hurn, and D. M. Van Winkle Estradiol abolishes reduction in cell death by the opioid agonist Met5-enkephalin after oxygen glucose deprivation in isolated cardiomyocytes from both sexes Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H409 - H415. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gardner, G. L. Brower, T. G. Voloshenyuk, and J. S. Janicki Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H198 - H204. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cao, L. Liu, W. Packwood, M. Merkel, P. D. Hurn, and D. M. Van Winkle Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H302 - H310. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shimozawa, K. Okajima, and N. Harada Estrogen and isoflavone attenuate stress-induced gastric mucosal injury by inhibiting decreases in gastric tissue levels of CGRP in ovariectomized rats Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G615 - G619. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gardner, G. L. Brower, and J. S. Janicki Effects of dietary phytoestrogens on cardiac remodeling secondary to chronic volume overload in female rats J Appl Physiol, October 1, 2005; 99(4): 1378 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Magness, T. M. Phernetton, T. C. Gibson, and D.-b. Chen Uterine blood flow responses to ICI 182 780 in ovariectomized oestradiol-17{beta}-treated, intact follicular and pregnant sheep J. Physiol., May 15, 2005; 565(1): 71 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
R M Fleming What Effect, if any, does Soy Protein have on Breast Tissue? Integr Cancer Ther, September 1, 2003; 2(3): 225 - 228. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||